Terms: = Breast cancer AND RAD51B, ENSG00000182185, 5890, RAD51L1, O15315, hREC2, R51H2, REC2, MGC34245 AND Treatment
10 results:
1. treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E
Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742
[TBL] [Abstract] [Full Text] [Related]
2. Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort.
Leibowitz BD; Dougherty BV; Bell JSK; Kapilivsky J; Michuda J; Sedgewick AJ; Munson WA; Chandra TA; Dry JR; Beaubier N; Igartua C; Taxter T
BMC Cancer; 2022 May; 22(1):587. PubMed ID: 35643464
[TBL] [Abstract] [Full Text] [Related]
3. Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial.
Thiery-Vuillemin A; de Bono J; Hussain M; Roubaud G; Procopio G; Shore N; Fizazi K; Dos Anjos G; Gravis G; Joung JY; Matsubara N; Castellano D; Degboe A; Gresty C; Kang J; Allen A; Poehlein C; Saad F
Lancet Oncol; 2022 Mar; 23(3):393-405. PubMed ID: 35157830
[TBL] [Abstract] [Full Text] [Related]
4. Homologous Recombination Deficiency: cancer Predispositions and treatment Implications.
Toh M; Ngeow J
Oncologist; 2021 Sep; 26(9):e1526-e1537. PubMed ID: 34021944
[TBL] [Abstract] [Full Text] [Related]
5. breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of an AC-taxane versus AC-free regimen and paclitaxel versus docetaxel in patients with lymph node-positive breast cancer: Final results of the National Surgical Adjuvant Study of breast cancer 02 trial, a randomized comparative phase 3 study.
Watanabe T; Kuranami M; Inoue K; Masuda N; Aogi K; Ohno S; Iwata H; Mukai H; Uemura Y; Ohashi Y
Cancer; 2017 Mar; 123(5):759-768. PubMed ID: 28081304
[TBL] [Abstract] [Full Text] [Related]
7. The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.
Bayraktar S; Thompson PA; Yoo SY; Do KA; Sahin AA; Arun BK; Bondy ML; Brewster AM
Oncologist; 2013; 18(5):493-500. PubMed ID: 23635555
[TBL] [Abstract] [Full Text] [Related]
8. Effect of PP2A on p34SEI-1 expression in response to ionizing radiation in MCF-7 human breast cancer cells.
Jung S; Jeong HK; Shin J; Lee MS
Int J Oncol; 2011 May; 38(5):1475-82. PubMed ID: 21344158
[TBL] [Abstract] [Full Text] [Related]
9. Recombination activator function of the novel RAD51- and rad51b-binding protein, human EVL.
Takaku M; Machida S; Hosoya N; Nakayama S; Takizawa Y; Sakane I; Shibata T; Miyagawa K; Kurumizaka H
J Biol Chem; 2009 May; 284(21):14326-36. PubMed ID: 19329439
[TBL] [Abstract] [Full Text] [Related]
10. The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells.
Zeidler M; Varambally S; Cao Q; Chinnaiyan AM; Ferguson DO; Merajver SD; Kleer CG
Neoplasia; 2005 Nov; 7(11):1011-9. PubMed ID: 16331887
[TBL] [Abstract] [Full Text] [Related]
